Expression of Sestrin Genes in Radiotherapy for Prostate Cancer and Its Association With Fatigue: A Proof-of-Concept Study

Genetic factors that influence inflammation and energy production/expenditure in cells may affect patient outcomes following treatment with external beam radiation therapy (EBRT). Sestrins, stress-inducible genes with antioxidant properties, have recently been implicated in several behaviors including fatigue. This proof-of-concept study explored whether the sestrin family of genes (SESN1, SESN2, and SESN3) were differentially expressed from baseline to the midpoint of EBRT in a sample of 26 Puerto Rican men with nonmetastatic prostate cancer. We also examined whether changes in expression of these genes were associated with changes in fatigue scores during EBRT. Method: Participants completed the 13-item Functional Assessment of Cancer Therapy—Fatigue subscale, Spanish version. Whole blood samples were collected at baseline and at the midpoint of EBRT. Gene expression data were analyzed using the limma package in the R (version R 2.14.0.) statistical software. Linear models and empirical Bayes moderation, adjusted for radiation fraction (total number of days of prescribed radiation treatment), were used to examine potential associations between changes in gene expression and change in fatigue scores. Results: Expression of SESN3 (adjusted p < .01, log fold change −0.649) was significantly downregulated during EBRT, whereas the expressions of SESN1 and SESN2 remained unchanged. After adjustment for radiation fraction, change in SESN3 expression was associated with change in fatigue during EBRT (false discovery rate <.01). Conclusions: Downregulation of SESN3, a novel pharmacoactive stress response gene, was associated with fatigue intensification during EBRT. SESN3 may serve as an interventional target and a biomarker for the cellular and molecular events associated with EBRT-related fatigue.

[1]  E. Ropelle,et al.  Physical exercise increases Sestrin 2 protein levels and induces autophagy in the skeletal muscle of old mice , 2017, Experimental Gerontology.

[2]  Suzanne M. Miller,et al.  Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis , 2017, JAMA oncology.

[3]  P. Reddy,et al.  Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[4]  G. Milne,et al.  Oxidative stress in relation to diet and physical activity among premenopausal women , 2016, British Journal of Nutrition.

[5]  J. Xie,et al.  Investigations on the antifatigue and antihypoxic effects of Paecilomyces hepiali extract. , 2016, Molecular medicine reports.

[6]  L. Sechrest,et al.  Clinical Predictors of Fatigue in Men With Non-Metastatic Prostate Cancer Receiving External Beam Radiation Therapy. , 2015, Clinical journal of oncology nursing.

[7]  L. Teng,et al.  Studies on the Antifatigue Activities of Cordyceps militaris Fruit Body Extract in Mouse Model , 2015, Evidence-based complementary and alternative medicine : eCAM.

[8]  Jian Huang,et al.  AMPK binds to Sestrins and mediates the effect of exercise to increase insulin-sensitivity through autophagy. , 2015, Metabolism: clinical and experimental.

[9]  C. Cleeland,et al.  The symptom burden of treatment‐naive patients with head and neck cancer , 2015, Cancer.

[10]  R. Elswick,et al.  Association of mitochondrial dysfunction and fatigue: A review of the literature , 2014, BBA clinical.

[11]  Kallenborn-GerhardtWiebke,et al.  Antioxidant activity of sestrin 2 controls neuropathic pain after peripheral nerve injury. , 2013 .

[12]  M. Karin,et al.  Sestrins orchestrate cellular metabolism to attenuate aging. , 2013, Cell metabolism.

[13]  J. Zierath,et al.  Sestrin 3 regulation in type 2 diabetic patients and its influence on metabolism and differentiation in skeletal muscle. , 2013, American journal of physiology. Endocrinology and metabolism.

[14]  Claudia X. Aguado Loi,et al.  Risk factors associated with increased depressive symptoms among Latinas diagnosed with breast cancer within 5 years of survivorship , 2013, Psycho-oncology.

[15]  F. Sanchis-Gomar Sestrins: Novel antioxidant and AMPK‐modulating functions regulated by exercise? , 2013, Journal of cellular physiology.

[16]  L. Saligan,et al.  Mitochondria-Related Gene Expression Changes Are Associated With Fatigue in Patients With Nonmetastatic Prostate Cancer Receiving External Beam Radiation Therapy , 2013, Cancer nursing.

[17]  J. Armes,et al.  The prevalence and severity of fatigue in men with prostate cancer: a systematic review of the literature , 2013, Supportive Care in Cancer.

[18]  P. J. Munson,et al.  Upregulation of α-synuclein during localized radiation therapy signals the association of cancer-related fatigue with the activation of inflammatory and neuroprotective pathways , 2013, Brain, Behavior, and Immunity.

[19]  L. Saligan,et al.  A systematic review of the association between immunogenomic markers and cancer-related fatigue , 2012, Brain, Behavior, and Immunity.

[20]  P. Fransson Fatigue in prostate cancer patients treated with external beam radiotherapy: a prospective 5-year long-term patient-reported evaluation. , 2010, Journal of cancer research and therapeutics.

[21]  P. Gascón,et al.  Psychometric properties of the Perform Questionnaire: a brief scale for assessing patient perceptions of fatigue in cancer , 2010, Supportive Care in Cancer.

[22]  N. Hay,et al.  Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. , 2008, Cancer cell.

[23]  C. Cleeland Symptom burden: multiple symptoms and their impact as patient-reported outcomes. , 2007, Journal of the National Cancer Institute. Monographs.

[24]  P. Chumakov,et al.  Repression of sestrin family genes contributes to oncogenic Ras-induced reactive oxygen species up-regulation and genetic instability. , 2007, Cancer research.

[25]  Kevin Fiscella,et al.  Mechanisms of cancer-related fatigue. , 2007, The oncologist.

[26]  E. Berthelet,et al.  Prospective evaluation of the prevalence and severity of fatigue in patients with prostate cancer undergoing radical external beam radiotherapy and neoadjuvant hormone therapy. , 2006, The Canadian journal of urology.

[27]  R. Craddock,et al.  Identifying illness parameters in fatiguing syndromes using classical projection methods. , 2006, Pharmacogenomics.

[28]  Lora Packel,et al.  Cancer-related fatigue. , 2006, Archives of physical medicine and rehabilitation.

[29]  G. Morrow,et al.  Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer , 2005, Cancer.

[30]  E. Koonin,et al.  Regeneration of Peroxiredoxins by p53-Regulated Sestrins, Homologs of Bacterial AhpD , 2004, Science.

[31]  D. Cella,et al.  Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. , 2002, Journal of pain and symptom management.

[32]  P. Stone,et al.  Fatigue in patients with cancers of the breast or prostate undergoing radical radiotherapy. , 2001, Journal of pain and symptom management.

[33]  D. Cella,et al.  Spanish language translation and initial validation of the functional assessment of cancer therapy quality-of-life instrument. , 1998, Medical care.

[34]  P. Reddy,et al.  Therapeutic Strategies for Mitochondrial Dysfunction and Oxidative Stress in Age-Related Metabolic Disorders. , 2017, Progress in molecular biology and translational science.

[35]  A. Budanov,et al.  Sensing the Environment Through Sestrins: Implications for Cellular Metabolism. , 2016, International review of cell and molecular biology.

[36]  H. von Melchner,et al.  Antioxidant activity of sestrin 2 controls neuropathic pain after peripheral nerve injury. , 2013, Antioxidants & redox signaling.